📣New study: semaglutide compared with non-GLP1R agonist anti-obesity medications associated with lower risk for incident (HR = 0.27) and recurrent (HR = 0.44) suicidal ideation, consistent across sex, age and ethnicity stratification. nature.com/articles/s4159… H/t @ChrisPalmerMD
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts